Report Overview

The EU Human Papillomavirus Vaccine market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Human Papillomavirus Vaccine have widely acclaimed as a sweeping vaccine innovation for the universal bennet of all the women and girls. Every year, thousands of women develop cervical cancer, and thousands die from the disease



Market Drivers

The major factors for the growth of the human papillomavirus (HPV) vaccine market include the approval of new HPV vaccines, and increasing initiatives by government & private organizations for early screening & vaccination. The increasing incidence of HPV associated cancers such as anal, oropharynx, and genital parts and growing demand for HPV vaccines to help reduce the infections are factors likely to bolster healthy growth of the market in the forthcoming years